Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Thomas Marron is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0
Gulati, N., Block, B. R., Mehta, J. & Marron, T. U., 16 Jul 2026, In: JAMA Oncology. 12, 7, p. 689-690 2 p.Research output: Contribution to journal › Short survey › peer-review
-
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma
Lombardi, P., Ramon-Gil, E., Raja, R. Q., Brunetti, L., Manfredi, G. F., Zhou, Z., Merces, G., Cappuyns, S., Maria Fulgenzi, C. A., D’Alessio, A., Torkpour, A., Celsa, C., Stefanini, B., Yang, H., Crowley, F., Marron, T. U., Saeed, A., Pinter, M., Scheiner, B. & Huang, Y. H. & 35 others, , 2026, (Accepted/In press) In: Journal of Hepatology.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Author Correction: Innovative approaches for lung cancer screening and interception (Nature Reviews Clinical Oncology, (2026), 10.1038/s41571-026-01131-4)
Zhang, J., Park, M. D., Pandya, T., Shum, E., Wu, J., Heeke, S., Salehi-Rad, R., Marron, T. U., Wei, Z., Li, H., Blum, T. G., Heymach, J. V., Dubinett, S. M., Yang, P. C., Swanton, C. & Merad, M., May 2026, In: Nature Reviews Clinical Oncology. 23, 5, p. 390 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials
Fumet, J. D., Dugage, M. R., Danlos, F. X., Hueso, T., Pinato, D. J., Luke, J., Bermejo, I. M., Lorusso, P., Brody, J., Harrington, K., Segal, N. H., Diab, A., Garralda, E., Marron, T., Houot, R., Champiat, S. & Marabelle, A., Jul 2026, In: Annals of Oncology. 37, 7, p. 892-901 10 p.Research output: Contribution to journal › Review article › peer-review
-
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study
Adib, E., Nassar, A. H., Lee, K. N., Fusco, F., Crowley, F., Baena, J., Worth, J. E., Abi Jaoude, J., Addeo, A., Bou Farhat, E., Rakaee, M., Amini, A., Lambden, J., Rost, M., Bolnykh, I., Aboubakar Nana, F., Aujayeb, A., Cortellini, A., Newsom-Davis, T. & Camidge, D. R. & 9 others, , Apr 2026, In: JTO Clinical and Research Reports. 7, 4, 100949.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Pheast Therapeutics to Host Educational KOL Webinar on Emerging Role of Macrophage Checkpoint Biology for the Treatment of Solid Tumors
3/08/26 → 4/08/26
11 items of Media coverage
Press/Media
-
Clinical Trials – June 18, 2026 Cantargia starts new investigator-initiated lung cancer prevention study Cantargia has reported that the first patient has been dosed in a Phase 2 clinical trial investigating nadunolimab in up to 59 current or previous smo
Merad, M., Samstein, R. & Marron, T.
18/06/26
1 item of Media coverage
Press/Media
-
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
Merad, M., Samstein, R. & Marron, T.
13/06/26
1 item of Media coverage
Press/Media
-
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
Merad, M., Samstein, R. & Marron, T.
10/06/26
19 items of Media coverage
Press/Media
-
Mount Sinai Researchers to Present Expansive Range of Cancer Research at 2026 ASCO Annual Meeting
Hirsch, F., Hirsch, F., Richter, J., Galsky, M., Parsons, R., Marron, T., van Gerwen, M., Mascarenhas, J. & Roof, S.
27/05/26 → 28/05/26
4 items of Media coverage
Press/Media